HCA Healthcare reports 3.6 percent revenue growth while HCA Healthcare stock costs EUR 398.20

Published on 10/28/2026 at 11:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Net income fell 3.9 percent in the third quarter. HCA Healthcare stock costs EUR 398.20 on October 28, 2026, while revenue reached USD 19.849 billion.

Quarterly results reshape the outlook

Third-quarter revenue rose 3.6 percent to USD 19.849 billion on October 27, 2026.
HCA Healthcare expects 2026 revenue of USD 77.0 billion to USD 79.5 billion.
HCA Healthcare stock traded at EUR 398.20 at 11:28 a.m. CET at Lang & Schwarz on October 28, 2026.
The quarterly dividend of USD 0.78 per share is payable on December 29, 2026.

HCA Healthcare, US40412C1018, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) reported third-quarter revenue growth of 3.6 percent to USD 19.849 billion on October 27, 2026, while HCA Healthcare stock traded at EUR 398.20 at Lang & Schwarz on October 28, 2026 at 11:28 a.m. CET. The company said operating results should land in the upper half of its 2026 guidance ranges, according to the HCA Healthcare release.

Revenue growth meets payer pressure

The third quarter ended September 30, 2026, produced USD 19.849 billion in revenue versus USD 19.161 billion a year earlier. Net income attributable to HCA Healthcare fell 3.9 percent to USD 1.579 billion from USD 1.643 billion, while adjusted earnings per share rose 3.7 percent to USD 7.22.

Patient volume remained a counterweight to reimbursement pressure. Same-facility equivalent admissions increased 3.0 percent, and emergency-room visits rose 5.1 percent from the prior-year period. Same-facility inpatient surgeries declined 1.4 percent, while outpatient surgeries fell 3.7 percent.

What does the outlook mean?

HCA estimates that a shift toward uninsured patients reduced third-quarter income before income taxes by USD 400 million. Adjusted EBITDA still increased 1.2 percent to USD 3.918 billion, but its margin declined to 19.7 percent from 20.2 percent in the third quarter of 2025.

The company retained 2026 revenue guidance of USD 77.0 billion to USD 79.5 billion and adjusted EBITDA guidance of USD 15.4 billion to USD 16.1 billion. The upper-half expectation therefore depends on volume growth and operating improvements offsetting payer-mix pressure.

Dividend sets the next date

HCA Healthcare declared a quarterly cash dividend of USD 0.78 per share on October 27, 2026. The dividend is payable on December 29, 2026, to shareholders of record on December 15, 2026, according to the company release.

Stock trades below the latest results

At Lang & Schwarz, HCA Healthcare stock was trading intraday at EUR 398.20 on October 28, 2026 at 11:28 a.m. CET. The quote is presented without a daily comparison because a dated Xetra close could not be established in the reviewed venue data.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.